- Home
- GHG vs QNCX Comparison
GHG vs QNCX Comparison
Compare GHG & QNCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
GHG
GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
Current Price
Current Price
Company Overview
Basic Information| Metric | GHG | QNCX |
|---|---|---|
| Founded | 2004 | 2012 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Hotels/Resorts | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 171.6M | 167.0M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | GHG | QNCX |
|---|---|---|
| Price | $1.40 | $0.21 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | 32.8K | ★ 142.3M |
| Earning Date | 03-30-2026 | 03-23-2026 |
| Dividend Yield | ★ 7.14% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.25 | N/A |
| Revenue | ★ $166,761,937.00 | N/A |
| Revenue This Year | $19.02 | N/A |
| Revenue Next Year | $8.26 | N/A |
| P/E Ratio | $5.60 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.39 | $0.13 |
| 52 Week High | $3.25 | $4.55 |
Technical Indicators
Market Signals| Indicator | GHG | QNCX |
|---|---|---|
| Relative Strength Index (RSI) | 37.02 | 29.18 |
| Support Level | $1.41 | $0.22 |
| Resistance Level | $1.51 | $0.98 |
| Average True Range (ATR) | 0.04 | 0.35 |
| MACD | -0.00 | -0.05 |
| Stochastic Oscillator | 22.17 | 4.07 |
Price Performance
Historical ComparisonAbout GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share
GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.
About QNCX Quince Therapeutics Inc.
Quince Therapeutics Inc is preclinical stage biopharmaceutical company focused on advancing precision therapeutics for debilitating and rare diseases. The company discovered a broad bone-targeting drug platform designed to precisely deliver small molecules, peptides, or large molecules directly to the site of bone fracture and disease to promote rapid healing with fewer off-target safety concerns compared to non-targeted therapeutics. Company pipeline includes Ataxia-Telangiectasia(EryDex), Duchenne Muscular Dystrophy, New Indications and Program Expansion Potential.